
Aditi Dutt
Examiner (ID: 15807, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1675 |
| Total Applications | 622 |
| Issued Applications | 221 |
| Pending Applications | 78 |
| Abandoned Applications | 328 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15227691
[patent_doc_number] => 10501556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Compositions and methods for treating cocaine-related disorders
[patent_app_type] => utility
[patent_app_number] => 15/677401
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8831
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15677401
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/677401 | Compositions and methods for treating cocaine-related disorders | Aug 14, 2017 | Issued |
Array
(
[id] => 12766285
[patent_doc_number] => 20180147263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => METHOD OF TREATING NEUROLOGICAL DISORDER BY ENHANCING OUTGROWTH OF NEURITE
[patent_app_type] => utility
[patent_app_number] => 15/604654
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604654 | METHOD OF TREATING NEUROLOGICAL DISORDER BY ENHANCING OUTGROWTH OF NEURITE | May 24, 2017 | Abandoned |
Array
(
[id] => 11979337
[patent_doc_number] => 20170283491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS'
[patent_app_type] => utility
[patent_app_number] => 15/593845
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 43709
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15593845
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/593845 | Method of providing disease-specific binding molecules and targets | May 11, 2017 | Issued |
Array
(
[id] => 14210701
[patent_doc_number] => 20190117735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => BIOMARKERS FOR MONITORING IMMUNE TRANSFORMATION
[patent_app_type] => utility
[patent_app_number] => 16/092561
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092561
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092561 | Biomarkers for monitoring immune transformation | Apr 23, 2017 | Issued |
Array
(
[id] => 11979620
[patent_doc_number] => 20170283774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'METHODS FOR EFFICIENT DERIVATION OF HUMAN MOTOR NEURONS FROM DIVERSE SPINAL REGIONS'
[patent_app_type] => utility
[patent_app_number] => 15/475831
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11297
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15475831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/475831 | Methods for efficient derivation of human motor neurons from diverse spinal regions | Mar 30, 2017 | Issued |
Array
(
[id] => 14214003
[patent_doc_number] => 20190119386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => ANTI-RYK ANTIBODIES AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/086958
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086958
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086958 | Anti-Ryk antibodies and methods of using the same | Mar 27, 2017 | Issued |
Array
(
[id] => 11948223
[patent_doc_number] => 20170252375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines'
[patent_app_type] => utility
[patent_app_number] => 15/470672
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9093
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470672
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470672 | Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines | Mar 26, 2017 | Abandoned |
Array
(
[id] => 16391036
[patent_doc_number] => 20200331977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => NERVE GROWTH FACTOR FUSION PROTEIN, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/085984
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085984 | Nerve growth factor fusion protein, preparation method and use thereof | Mar 16, 2017 | Issued |
Array
(
[id] => 13926243
[patent_doc_number] => 20190046637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => MATERIALS AND METHODS FOR MITIGATING IMMUNE-SENSITIZATION
[patent_app_type] => utility
[patent_app_number] => 16/079932
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079932 | MATERIALS AND METHODS FOR MITIGATING IMMUNE-SENSITIZATION | Feb 28, 2017 | Abandoned |
Array
(
[id] => 11689615
[patent_doc_number] => 20170165330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect'
[patent_app_type] => utility
[patent_app_number] => 15/439811
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8421
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15439811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/439811 | Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect | Feb 21, 2017 | Abandoned |
Array
(
[id] => 11689616
[patent_doc_number] => 20170165331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect'
[patent_app_type] => utility
[patent_app_number] => 15/439835
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8421
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15439835
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/439835 | Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect | Feb 21, 2017 | Abandoned |
Array
(
[id] => 16499996
[patent_doc_number] => 10865372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Neuron cultivation device, neuron cultivating method, cultivated neuron, analysis and identification of protein in axon bundle, and usage of cultivated neuron
[patent_app_type] => utility
[patent_app_number] => 16/094296
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 8590
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094296 | Neuron cultivation device, neuron cultivating method, cultivated neuron, analysis and identification of protein in axon bundle, and usage of cultivated neuron | Jan 31, 2017 | Issued |
Array
(
[id] => 13837233
[patent_doc_number] => 20190022101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => Treating Cochlear Synaptopathy
[patent_app_type] => utility
[patent_app_number] => 16/068260
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068260 | Treating Cochlear Synaptopathy | Jan 5, 2017 | Abandoned |
Array
(
[id] => 14185767
[patent_doc_number] => 20190112588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES
[patent_app_type] => utility
[patent_app_number] => 15/781681
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/781681 | COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES | Dec 7, 2016 | Abandoned |
Array
(
[id] => 17074894
[patent_doc_number] => 11111279
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Nato3 mutant polypeptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/776580
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 19
[patent_no_of_words] => 22838
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/776580 | Nato3 mutant polypeptides and uses thereof | Nov 17, 2016 | Issued |
Array
(
[id] => 19731262
[patent_doc_number] => 12209253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Development of spinal cord on a microfluidic chip
[patent_app_type] => utility
[patent_app_number] => 15/352289
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 59
[patent_no_of_words] => 16256
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352289
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352289 | Development of spinal cord on a microfluidic chip | Nov 14, 2016 | Issued |
Array
(
[id] => 15306439
[patent_doc_number] => 10517900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => In vitro model for neuronal death
[patent_app_type] => utility
[patent_app_number] => 15/352552
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 13
[patent_no_of_words] => 7573
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352552
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352552 | In vitro model for neuronal death | Nov 14, 2016 | Issued |
Array
(
[id] => 11602486
[patent_doc_number] => 20170119787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'MODULATING THE PRODUCTION OF NEURONS AND/OR OLIGODENDROCYTES FROM WHITE MATTER PROGENITOR CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/352249
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16815
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352249
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352249 | Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells | Nov 14, 2016 | Issued |
Array
(
[id] => 14454553
[patent_doc_number] => 10323229
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-06-18
[patent_title] => Three-dimensional human stem cell-derived cortical spheroid model
[patent_app_type] => utility
[patent_app_number] => 15/350395
[patent_app_country] => US
[patent_app_date] => 2016-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 132
[patent_no_of_words] => 18774
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15350395
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/350395 | Three-dimensional human stem cell-derived cortical spheroid model | Nov 13, 2016 | Issued |
Array
(
[id] => 14099261
[patent_doc_number] => 20190091306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => METHOD FOR VACCINATION AGAINST A SELF-ANTIGEN IN A HUMAN PATIENT
[patent_app_type] => utility
[patent_app_number] => 15/772572
[patent_app_country] => US
[patent_app_date] => 2016-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772572
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/772572 | Method for vaccination against a self-antigen in a human patient | Nov 1, 2016 | Issued |